A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as ...

Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it ...

Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...

As next-generation sequencing (NGS) workflows increasingly rely on lower DNA and RNA inputs and greater automation, minimising sample loss has become critical. Azenta Life Sciences offers a range ...

Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime. BV is characterized by unpleasant odors, ...

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or ...

Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new ...

A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...